Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone

Ophthalmology
Rola N HamamJohnny M Khoury

Abstract

To report a patient with Mycobacterium chelonae keratitis after LASIK and discuss therapeutic measures. Interventional case report and literature review. A healthy, 25-year-old man presented 6 weeks after LASIK with infectious keratitis in the left eye. Scrapings were obtained from the central stromal bed after lifting the flap and inoculated on culture media. Response to medical treatment. Mycobacterium chelonae was identified from stromal bed scrapings. The protracted course of the infection necessitated surgical debridement and flap amputation with slow and suboptimal response to prolonged (14 weeks) treatment with topical amikacin 3.3%, clarithromycin 1%, and levofloxacin 0.5%. The substitution of levofloxacin 0.5% with gatifloxacin 0.3% resulted in closure of the epithelial defect within 1 week and resolution of the infiltrates in 3 weeks. The combined regimen of gatifloxacin 0.3%, amikacin 3.3%, and clarithromycin 1% was continued for a total of 4 months. The patient remains infection free 1 year after stopping all antibiotics. Treatment of post-LASIK nontuberculous mycobacteria remains a challenge. Institution of combination therapy including fortified amikacin, clarithromycin 1%, and a fourth-generation fluoroquinolone ...Continue Reading

References

Nov 1, 1982·Archives of Ophthalmology·R A Eiferman, J I Stagner
Jan 1, 1993·American Journal of Ophthalmology·D G Hwang, R Biswell
Oct 1, 1998·Ophthalmology·J G FordD Miller
Oct 8, 1999·The Journal of Antimicrobial Chemotherapy·S H Gillespie, O Billington
Jun 8, 2001·Journal of Medical Microbiology·S H GillespieD Everett
Jun 27, 2001·Ophthalmology·G A KouyoumdjianR E Damiano
Dec 4, 2001·American Journal of Ophthalmology·N S ChandraG N Holland
Dec 6, 2001·Ophthalmology·A SolomonW W Culbertson
Mar 27, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary P HolmesSamuel F Fulcher
Apr 30, 2002·Journal of Cataract and Refractive Surgery·JoAnn GiaconiChristopher N Ta
Jul 20, 2002·Cornea·Samuel F A FulcherGary P Holmes
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Barbara A Brown-ElliottRebecca W Wilson
Feb 13, 2003·Ophthalmology·Denise FreitasRubens Belfort
Mar 8, 2003·Ophthalmology·Carol L KarpWilliam W Culbertson
Jun 7, 2003·International Journal of Antimicrobial Agents·J C Rodriguez DíazG Royo
Oct 9, 2003·Klinische Monatsblätter für Augenheilkunde·Thomas KohnenKlaus-Peter Hunfeld
Nov 8, 2003·Journal of Cataract and Refractive Surgery·Renée SolomonJonathan B Rubenstein
Jan 27, 2004·Current Opinion in Ophthalmology·Richard Tipperman

❮ Previous
Next ❯

Citations

Sep 1, 2006·Photomedicine and Laser Surgery
May 15, 2007·Current Opinion in Infectious Diseases·Philip Aloysius Thomas, Pitchairaj Geraldine
Nov 10, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Junjie ZhangHongmin Zhang
Mar 26, 2011·Journal of Cataract and Refractive Surgery·Takefumi YamaguchiJun Shimazaki
May 13, 2008·Journal of Cataract and Refractive Surgery·Ahsan M KhanCharles Bouchard
Oct 30, 2007·Journal of Cataract and Refractive Surgery·Majid MoshirfarLadan Espandar
Jun 26, 2007·Journal of Cataract and Refractive Surgery·Jose de la CruzRoberto Pineda
Feb 27, 2007·Journal of Cataract and Refractive Surgery·Majid MoshirfarThomas E Clinch
Sep 10, 2011·Clinical & Experimental Ophthalmology·Dalia O GirgisDarlene Miller
Jun 25, 2015·BioMed Research International·Wajiha J KheirRola N Hamam
Dec 15, 2015·International Journal of Mycobacteriology·Ali Akbar VelayatiMehdi Mirsaeidi
Dec 6, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H-S Chu, F-R Hu
Sep 11, 2018·Journal of Refractive Surgery·Hsin-Yu LiuI-Jong Wang
Oct 16, 2015·Antimicrobial Agents and Chemotherapy·Thet Tun AungRoger W Beuerman
Mar 30, 2017·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Hawra Al-Ghafli, Sahal Al-Hajoj
Dec 14, 2017·Case Reports in Ophthalmological Medicine·Jaime D MartinezLeejee H Suh
Jul 23, 2021·Journal of Cataract and Refractive Surgery·Daniel GarcerantStephanie L Watson
Jun 15, 2007·Current Opinion in Ophthalmology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.